Walvax Biotechnology Co. Ltd Financials

Market Capitalization CN¥23.46 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	183.38
Forward PE	32.60
Price to Sales TTM	CN¥7.58
Price to Book MRQ	CN¥2.45
Enterprise to Revenue	7.33
Enterprise to EBITDA	33.91

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	3.95%
Operating Margin	37.27%
Return on Assets TTM	1.42%
Return on Equity TTM	1.41%

Income Statement

Revenue TTM	CN¥3,097,074,176
Revenue per Share TTM	CN¥1.94
Quarterly Revenue Growth	-28.50%
Gross Profit TTM	CN¥3,516,216,173
EBITDA	CN¥696,141,855
Net Income to Common TTM	CN¥122,372,384
Diluted EPS TTM	CN¥0.08
Quarterly Earnings Growth YoY	-12.60%

Balance Sheet

Total Cash MRQ	CN¥3,622,884,608
Total Cash per Share MRQ	CN¥2.27
Total Debt MRQ	CN¥
Total Debt to Equity MRQ	6.18
Current Ratio MRQ	3.10
Book Value per Share MRQ	CN¥6.00

Cash Flow

Operating Cash Flow TTM	CN¥832,237,056
Levered Free Cash Flow TTM	CN¥19,202,260

300142 Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	1,599,350,016
Float Shares	1,383,644,403
Avg 10 Volume	23,994,342
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	13.65%
% Held by Institutions	17.76%

Stock Price Summary

Beta	0.69
Fifty Two Week Low	CN¥9.78
Fifty Two Week High	CN¥19.18
Fifty Two Week Change	-56.88%
Day 50 MA	CN¥14.66
Day 200 MA	CN¥13.79

Dividends and Splits

Forward Annual Dividend Rate	CN¥0.01
Forward Annual Dividend Yield	0.07%
Trailing Annual Dividend Rate	CN¥0.01
Trailing Annual Dividend Yield	0.07%
Payout Ratio	13.05%
Dividend Date
Ex Dividend Date	2024-05-30
Last Split Factor
Last Split Date	2015-10-14